Progress-Werk Oberkirch AG

  • WKN: 696800
  • ISIN: DE0006968001
  • Land: Deutschland

Nachricht vom 26.08.2021 | 14:00

PWO decides not to utilize KfW loans

Progress-Werk Oberkirch AG / Key word(s): Financing
PWO decides not to utilize KfW loans

26-Aug-2021 / 14:00 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Ad hoc disclosure pursuant to Art. 17 MAR

PWO decides not to utilize KfW loans

Oberkirch, August 26, 2021 - The Executive Board of PWO AG has today resolved to terminate the existing KfW loans, which have not been utilized to date, early.

The general prohibition on dividend payments therefore also ceases to apply.

The loan agreements from the KfW Special Program 2020 ("KfW-Unternehmerkredit 037") with a volume of EUR 30 million were concluded in February 2021 in order to further extend the available financial scope and to better mitigate the risks associated with the potentially longer duration of the coronavirus pandemic. Not including the KfW loans, PWO again had undrawn lines of credit of around EUR 100 million on June 30, 2021.

Despite the challenging market conditions, business went well in the first half of 2021. The current success is based on the strong performance of the international sites and the increasingly positive effects of the adjustments made at the Oberkirch production site so far. We thus successfully counteracted the negative economic impact of the coronavirus pandemic. At the same time, we are working hard to continue all productivity programs, especially in order to ensure the market success of the Oberkirch production site in the future. The good new business in the first half of the year has also made us confident about the future.

We occupy an excellent position in the three mobility trends of electrification, safety and comfort and enjoy a high reputation among our customers. The high performance of our international sites, the currently high level of new business and the extensive inquiries about a wide range of new projects all point to successful business performance in the years to come.

Progress-Werk Oberkirch AG
The Executive Board

End of ad hoc disclosure


26-Aug-2021 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

News im Fokus

Allianz SE: Allianz kündigt Abschluss eines Rückversicherungsvertrages in den USA an

03. Dezember 2021, 07:03

Aktueller Webcast

Deutsche Konsum REIT-AG

FY 2020/2021 Financial Results

16. Dezember 2021

Aktuelle Research-Studie

CEWE Stiftung & Co. KGaA

Original-Research: CEWE Stiftung & Co. KGaA (von GSC Research GmbH): Kaufen

02. Dezember 2021